HFE alleles in an Irish cystic fibrosis population

Area of Science:

• Genetics
• Medical Research

Background:

• Cystic Fibrosis (CF) presents with variable clinical manifestations, suggesting genetic modifiers.
• The hemochromatosis gene (HFE) is a potential modifier locus influencing CF phenotypes, including meconium ileus (MI) and liver disease.

Purpose of the Study:

• To investigate the carrier rates of HFE mutations C282Y and H63D in an Irish population of CF allele carriers.
• To explore the association between HFE mutations and CF complications, specifically meconium ileus.

Main Methods:

• Blood samples from CF patients were analyzed using PCR restriction enzyme analysis.
• HFE C282Y and H63D mutation status was determined in CF patients, including Delta F508 homozygotes with and without meconium ileus.

Main Results:

• The carrier frequency for the HFE C282Y mutation was 30.8% in Delta F508 homozygote patients with meconium ileus, compared to 12.5% in those without meconium ileus.
• This difference in C282Y carrier frequency did not reach statistical significance (p = 0.27).
• No Delta F508 homozygote CF patients were found to be homozygous for the HFE C282Y mutation.

Conclusions:

• The study did not find a statistically significant association between HFE C282Y or H63D mutations and meconium ileus in this Irish cohort of CF patients.
• Further research is needed to fully elucidate the role of HFE as a modifier gene in cystic fibrosis.
• The absence of HFE C282Y homozygosity in Delta F508 homozygotes warrants further investigation.